Dilaudid Related Published Studies
Well-designed clinical trials related to Dilaudid (Hydromorphone)
Potency ratio of hydromorphone and diacetylmorphine in substitution treatment for
long-term opioid dependency. [2011]
Effects of acepromazine, hydromorphone, or an acepromazine-hydromorphone combination on the degree of sedation in clinically normal dogs. [2010.11.15]
Steady-state pharmacokinetics of extended-release hydromorphone (OROS hydromorphone): a randomized study in healthy volunteers. [2010.09]
A randomized study to demonstrate noninferiority of once-daily OROS((R)) hydromorphone with twice-daily sustained-release oxycodone for moderate to severe chronic noncancer pain. [2010.09]
Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain. [2010.06]
Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study. [2010.06]
Evaluation of the abuse potential of extended release hydromorphone versus immediate release hydromorphone. [2010.02]
A comparison of the effects of hydromorphone HCl and a novel extended release hydromorphone on arterial blood gas values in conscious healthy dogs. [2010.02]
Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant
patients with chronic low back pain. [2010]
Double-blind injectable hydromorphone versus diacetylmorphine for the treatment
of opioid dependence: a pilot study. [2010]
Evaluation of the abuse potential of extended release hydromorphone versus
immediate release hydromorphone. [2010]
Randomized clinical trial comparing a patient-driven titration protocol of intravenous hydromorphone with traditional physician-driven management of emergency department patients with acute severe pain. [2009.10]
Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine. [2009.08]
Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial. [2009.02]
A randomized, double-blind comparison of OROS(R) hydromorphone and controlled-release morphine for the control of chronic cancer pain. [2008.10.31]
The side effects of morphine and hydromorphone patient-controlled analgesia. [2008.10]
Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline. [2008.07]
Comparison of the analgesic efficacy of hydromorphone and oxymorphone in dogs and cats: a randomized blinded study. [2008.07]
Relief of Incident Dyspnea in Palliative Cancer Patients: A Pilot, Randomized, Controlled Trial Comparing Nebulized Hydromorphone, Systemic Hydromorphone, and Nebulized Saline. [2008.03.19]
Conversion from standard opioid therapy to once-daily oral extended-release hydromorphone in patients with chronic cancer pain. [2008.03]
Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence of alcohol. [2008.01]
Metoclopramide versus hydromorphone for the emergency department treatment of migraine headache. [2008.01]
Metoclopramide Versus Hydromorphone for the Emergency Department Treatment of Migraine Headache. [2007.11.02]
A comparison of single-dose caudal clonidine, morphine, or hydromorphone combined with ropivacaine in pediatric patients undergoing ureteral reimplantation. [2007.06]
Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis. [2007.05]
Dose-related thermal antinociceptive effects of intravenous hydromorphone in cats. [2007.03]
Pharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphone. [2007.02.02]
Safety and efficacy of hydromorphone as an analgesic alternative to morphine in acute pain: a randomized clinical trial. [2006.08]
Comparative efficacy of oral extended-release hydromorphone and immediate-release hydromorphone in patients with persistent moderate to severe pain: two randomized controlled trials. [2005.06]
Clinical pharmacology and pharmacokinetics of once-daily hydromorphone hydrochloride extended-release capsules. [2005.05]
A laboratory study of hydromorphone and cyclazocine on smoking behavior in residential polydrug users. [2004.04]
Effect of fluticasone propionate nasal spray on bioavailability of intranasal hydromorphone hydrochloride in patients with allergic rhinitis. [2004.01]
A randomized study of the effect of oral lamotrigine and hydromorphone on pain and hyperalgesia following heat/capsaicin sensitization. [2003.09]
Pharmacokinetics and bioavailability of single-dose intranasal hydromorphone hydrochloride in healthy volunteers. [2003.07]
Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers. [2002.10]
The addition of hydromorphone to epidural fentanyl does not affect analgesia in early labour. [2002.06]
[Postoperative pain therapy with hydromorphone and metamizole. A prospective randomized study in intravenous patient-controlled analgesia (PCA)] [2001.10]
Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. [2001.09]
Effects of hydromorphone or oxymorphone, with or without acepromazine, on preanesthetic sedation, physiologic values, and histamine release in dogs. [2001.04.01]
Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans. [2001.02]
Pharmacodynamics of orally administered sustained- release hydromorphone in humans. [2001.01]
Effect of pre-emptive hydromorphone administration on postoperative pain relief--a randomized controlled trial. [2000.12.07]
Comparing the subjective, psychomotor, and physiological effects of intravenous hydromorphone and morphine in healthy volunteers. [2000.09]
Comparison of subcutaneous hydromorphone with intramuscular meperidine for immediate postoperative analgesia. [1999.07]
Continuous subcutaneous infusion of morphine vs. hydromorphone: a controlled trial. [1999.07]
Comparison of epidural morphine, hydromorphone and fentanyl for postoperative pain control in children undergoing orthopaedic surgery. [1999]
Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation. [1997.09]
Patient-controlled epidural analgesia: interactions between nalbuphine and hydromorphone. [1997.04]
Effects of ketorolac versus bupivacaine coadministration during patient-controlled hydromorphone epidural analgesia after thoracotomy procedures. [1997.03]
Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans. [1996.11]
Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone. [1996.11]
Epidural morphine vs hydromorphone in post-caesarean section patients. [1996.06]
A randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain. Canadian Palliative Care Clinical Trials Group. [1996.05]
A multidimensional comparison of morphine and hydromorphone patient-controlled analgesia. [1996.05]
Pain outcomes after thoracotomy: lumbar epidural hydromorphone versus intrapleural bupivacaine. [1995.10]
Intravenous versus epidural administration of hydromorphone. Effects on analgesia and recovery after radical retropubic prostatectomy. [1995.03]
Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphone. [1995.01]
Comparison of hydromorphone and meperidine for ureteral colic. [1994.11]
Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain. [1994.09.15]
Effects of diazepam and hydromorphone in triazolam-trained humans under a novel-response drug discrimination procedure. [1994.04]
Buprenorphine: duration of blockade of effects of intramuscular hydromorphone. [1994.04]
Hydromorphone patient-controlled analgesia (PCA) after coronary artery bypass surgery. [1994.03]
Comparison of hydromorphone continuous subcutaneous infusion and basal rate subcutaneous infusion plus PCA in cancer pain: a pilot study. [1993.04]
Morphine and hydromorphone epidural analgesia. A prospective, randomized comparison. [1992.12]
Epidural patient-controlled analgesia: influence of bupivacaine and hydromorphone basal infusion on pain control after cesarean delivery. [1992.11]
CSF and blood pharmacokinetics of hydromorphone and morphine following lumbar epidural administration. [1991.04]
Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain. [1991.02.23]
Clinical analgesic assay of repeated and single doses of heroin and hydromorphone. [1990.04]
Epidural hydromorphone with and without epinephrine for post-operative analgesia after cesarean delivery. [1989.03]
Patient-controlled subcutaneous hydromorphone versus continuous subcutaneous infusion for the treatment of cancer pain. [1988.09.21]
Pharmacokinetics of hydromorphone after intravenous, peroral and rectal administration to human subjects. [1988.03]
Well-designed clinical trials possibly related to Dilaudid (Hydromorphone)
PCA-derived factors that may be predictive of postoperative pain in pediatric
patients: a possible role for the PCA ratio. [2012]
Addition of pregabalin to multimodal analgesic therapy following ankle surgery: a
randomized double-blind, placebo-controlled trial. [2012]
Nerve stimulator versus ultrasound guidance for placement of popliteal catheters
for foot and ankle surgery. [2012]
The effects of preoperative intravenous acetaminophen in patients undergoing abdominal hysterectomy. [2011.12]
Intra- and postoperative very low dose intravenous ketamine infusion does not increase pain relief after major spine surgery in patients with preoperative narcotic analgesic intake. [2011.08]
Client satisfaction among participants in a randomized trial comparing oral methadone and injectable diacetylmorphine for long-term opioid-dependency. [2011.07.26]
Discriminative stimulus effects of tramadol in humans. [2011.07]
Evaluation of dexmedetomidine and ketamine in combination with opioids as injectable anesthesia for castration in dogs. [2011.05.01]
A comparison of epidural morphine with low dose bupivacaine versus epidural morphine alone on motor and respiratory function in dogs following splenectomy. [2011.05]
A comparison of sartorius versus quadriceps stimulation for femoral nerve block: a prospective randomized double-blind controlled trial. [2011.03]
History of reported sexual or physical abuse among long-term heroin users and their response to substitution treatment. [2011.01]
Client satisfaction among participants in a randomized trial comparing oral
methadone and injectable diacetylmorphine for long-term opioid-dependency. [2011]
The effects of preoperative intravenous acetaminophen in patients undergoing
abdominal hysterectomy. [2011]
History of reported sexual or physical abuse among long-term heroin users and
their response to substitution treatment. [2011]
A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery. [2010.12]
An enhanced bunionectomy model as a potential tool for early decision-making in the development of new analgesics. [2010.12]
Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusers. [2010.12]
The influence of time of day of administration on duration of opioid labor analgesia. [2010.10]
History of reported sexual or physical abuse among long-term heroin users and their response to substitution treatment. [2010.09.18]
Effectiveness of injection of local anesthetic into the retrobulbar space for postoperative analgesia following eye enucleation in dogs. [2010.07.15]
Characteristics and response to treatment among Aboriginal people receiving heroin-assisted treatment. [2010.05]
Comparison of the prophylactic anti-emetic efficacy of ramosetron and ondansetron in patients at high-risk for postoperative nausea and vomiting after total knee replacement. [2010.05]
Effects of opioids and anesthetic drugs on body temperature in cats. [2010.01]
Behavioral economic analysis of opioid consumption in heroin-dependent individuals: effects of alternative reinforcer magnitude and post-session drug supply. [2009.09.01]
Epidural analgesia compared with intravenous analgesia after pediatric posterior spinal fusion. [2009.09]
Diacetylmorphine versus methadone for the treatment of opioid addiction. [2009.08.20]
Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: rationale and design of the NAOMI study. [2009.06]
Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers. [2009.04.01]
The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism. [2009.04]
The pain quality response profile of oxymorphone extended release in the treatment of low back pain. [2009.02]
|
